A little girl's princess dress debut wowed her dad and brothers. One-year-old Capri's four siblings are all boys. Before the cherished baby girl arrived, her mom, Amanda Ivanelli, never thought ...

The annual literary festival staged around the state’s Capitol announced its lineup of national and Texas-based authors. From ...

Lilly Jay was a psychology student who toiled for five years to earn her degree, a feat celebrated by her then-husband Slater in a heartfelt post on X (formerly Twitter). Beyond her studies ...

An 8-year-old girl took an SUV from her Ohio home and drove for miles to a store where she was later found unharmed, authorities said. The girl, whose name was not released, and the vehicle — a ...

Production company Mandarin Vision released a teaser image for the new film, titled Girl, along with a shot of Shu behind the camera during a recent location shoot. Described as an original story ...

100% Cotton Machine wash,girls underwear Cloth material is very soft and comfy,and breathable. extra strength and durability. Comfort covered fabric waistband. Smooth, covered leg bands mean no ...

Celebrate your baby’s individuality by giving her a unique name. “A lot of people try to create something unique by taking a name like Madeline and spelling it M-A-D-E-L-Y-N-N,” Laura ...

Deepika Padukone and Ranveer Singh became proud parents to a beautiful baby girl on September 8, 2024. Just days after welcoming their little bundle of joy, Deepika gave her fans a sweet glimpse into ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra. Novo Nordisk’s American depositary receipts tumbled almost 6% ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...